Fluzone Tiv Sh 2026
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) · Injection, Suspension · Intramuscular
No FDA structured label text is available for Fluzone Tiv Sh 2026. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
Fluzone Tiv Sh 2026 NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 49281-315 | Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A… Injection, Suspension | Sanofi Vaccines US Inc. | BLA |
| 49281-626 | Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A… Injection, Suspension | Sanofi Vaccines US Inc. | BLA |
Frequently asked questions
Who makes Fluzone Tiv Sh 2026?
Fluzone Tiv Sh 2026 is listed by 1 labeler in the FDA NDC directory, including Sanofi Vaccines US Inc..